Ad
EPZM Quote Trading Chart Epizyme Inc.
home / stock / epzm / epzm quote
Quote | Epizyme Inc. (NASDAQ:EPZM)
| Last: | $1.47 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0 |
| Close: | $1.47 |
| High: | $0 |
| Low: | $0 |
| Volume: | 7,960 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
EPZM Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $1.47 | $0 | $1.47 | $0 | $0 | 7,960 | 09-08-2022 |
| $1.47 | $0 | $1.47 | $0 | $0 | 1,260 | 09-07-2022 |
| $1.47 | $0 | $1.47 | $0 | $0 | 18,540 | 08-26-2022 |
| $1.47 | $0 | $1.47 | $0 | $0 | 4,566 | 08-25-2022 |
| $1.47 | $1.49 | $1.47 | $1.5 | $1.47 | 22,276,017 | 08-11-2022 |
| $1.49 | $1.47 | $1.49 | $1.5 | $1.47 | 840,616 | 08-10-2022 |
| $1.49 | $1.49 | $1.49 | $1.49 | $1.47 | 2,475,121 | 08-09-2022 |
| $1.47 | $1.49 | $1.47 | $1.53 | $1.47 | 3,506,859 | 08-08-2022 |
| $1.52 | $1.48 | $1.52 | $1.53 | $1.48 | 1,194,881 | 08-05-2022 |
| $1.48 | $1.48 | $1.48 | $1.49 | $1.45 | 5,108,299 | 08-04-2022 |
| $1.49 | $1.48 | $1.49 | $1.49 | $1.48 | 3,138,845 | 08-03-2022 |
| $1.49 | $1.48 | $1.49 | $1.49 | $1.48 | 2,190,517 | 08-02-2022 |
| $1.48 | $1.48 | $1.48 | $1.49 | $1.48 | 1,653,201 | 08-01-2022 |
| $1.48 | $1.48 | $1.48 | $1.49 | $1.48 | 1,628,828 | 07-29-2022 |
| $1.48 | $1.48 | $1.48 | $1.49 | $1.48 | 2,798,975 | 07-28-2022 |
| $1.485 | $1.485 | $1.485 | $1.485 | $1.48 | 190,999 | 07-26-2022 |
| $1.49 | $1.47 | $1.49 | $1.49 | $1.47 | 1,485,481 | 07-25-2022 |
| $1.47 | $1.48 | $1.47 | $1.49 | $1.47 | 2,013,326 | 07-19-2022 |
| $1.48 | $1.48 | $1.48 | $1.5 | $1.48 | 4,190,606 | 07-18-2022 |
| $1.48 | $1.48 | $1.48 | $1.49 | $1.47 | 5,442,655 | 07-15-2022 |
Stock Information
Get EPZM Alerts
News, Short Squeeze, Breakout and More Instantly...
Epizyme Inc. Company Name:
EPZM Stock Symbol:
NASDAQ Market:
0.0% G/L:
$1.47 Last:
7,960 Volume:
$0 Open:
$1.47 Close:
Epizyme Inc. Website:
Ad
Important Investor News Alert (NASDAQ: CVKD)
-
LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...